Ad
Despite the calls for coordination, member states began recommending different age limits for the AstraZeneca vaccine (Photo: Cheshire East Council)

Advice on AstraZeneca varies across EU, amid blood clot fears

The European Commission has said national experts should work together with the European Medicines Agency (EMA) to develop a "coherent approach" across the EU for the AstraZeneca vaccine.

The call comes as a jumble of measures emerged from EU governments, in response to concerns over rare blood clots.

"Vaccination is a national competence, and member states may decide to follow a stricter approach when it comes to vaccines. [But] vaccination decisions in one member state can affec...

Get EU news that matters

Back our independent journalism by becoming a supporting member

Already a member? Login here

Author Bio

Elena is EUobserver's Managing Editor. She is from Spain and has studied journalism and new media in Spanish and Belgian universities. Previously she worked on European affairs at VoteWatch Europe and the Spanish news agency EFE.

Despite the calls for coordination, member states began recommending different age limits for the AstraZeneca vaccine (Photo: Cheshire East Council)

Tags

Author Bio

Elena is EUobserver's Managing Editor. She is from Spain and has studied journalism and new media in Spanish and Belgian universities. Previously she worked on European affairs at VoteWatch Europe and the Spanish news agency EFE.

Ad

Related articles

Ad
Ad